These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 20041244)

  • 21. Predictive value of nodal metastases on local recurrence in the management of differentiated thyroid cancer. Retrospective clinical study.
    Conzo G; Docimo G; Pasquali D; Mauriello C; Gambardella C; Esposito D; Tartaglia E; Della Pietra C; Napolitano S; Rizzuto A; Santini L
    BMC Surg; 2013; 13 Suppl 2(Suppl 2):S3. PubMed ID: 24267409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons.
    Takami H; Ito Y; Okamoto T; Yoshida A
    World J Surg; 2011 Jan; 35(1):111-21. PubMed ID: 21042913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of outcomes between hemithyroidectomy alone and hemithyroidectomy with elective unilateral central neck dissection in patients with papillary thyroid microcarcinoma.
    Son HJ; Kim JK; Jung YD; Jang GH; Seo YT; Kim DS; Park SH; Jeong YJ
    Head Neck; 2018 Nov; 40(11):2449-2454. PubMed ID: 30302890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
    Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
    Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
    Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
    Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective treatment of differentiated thyroid carcinoma.
    Gemsenjäger E; Heitz PU; Martina B
    World J Surg; 1997 Jun; 21(5):546-51; discussion 551-2. PubMed ID: 9204746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
    Hall CM; Snyder SK; Maldonado YM; Lairmore TC
    Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer.
    de Meer SG; Dauwan M; de Keizer B; Valk GD; Borel Rinkes IH; Vriens MR
    World J Surg; 2012 Jun; 36(6):1262-7. PubMed ID: 22270993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
    Rosário PW; Calsolari MR
    Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
    Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
    J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Papillary thyroid cancer: controversies in the management of neck metastasis.
    Davidson HC; Park BJ; Johnson JT
    Laryngoscope; 2008 Dec; 118(12):2161-5. PubMed ID: 19029855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
    Vassilopoulou-Sellin R; Schultz PN; Haynie TP
    Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up.
    Ito Y; Kudo T; Kobayashi K; Miya A; Ichihara K; Miyauchi A
    World J Surg; 2012 Jun; 36(6):1274-8. PubMed ID: 22270990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revisiting the guidelines issued by the Japanese Society of Thyroid Surgeons and Japan Association of Endocrine Surgeons: a gradual move towards consensus between Japanese and western practice in the management of thyroid carcinoma.
    Takami H; Ito Y; Okamoto T; Onoda N; Noguchi H; Yoshida A
    World J Surg; 2014 Aug; 38(8):2002-10. PubMed ID: 24671301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Completion total thyroidectomy in children with thyroid cancer secondary to the Chernobyl accident.
    Miccoli P; Antonelli A; Spinelli C; Ferdeghini M; Fallahi P; Baschieri L
    Arch Surg; 1998 Jan; 133(1):89-93. PubMed ID: 9438766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of prophylactic modified radical neck dissection for patients with low-risk papillary thyroid carcinoma measuring 1.1-3.0 cm: first report of a trial at Kuma Hospital.
    Ito Y; Tsushima Y; Masuoka H; Yabuta T; Fukushima M; Inoue H; Tomoda C; Kihara M; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
    Surg Today; 2011 Nov; 41(11):1486-91. PubMed ID: 21969150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distant, solitary skeletal muscle metastasis in recurrent papillary thyroid carcinoma.
    Bae SY; Lee SK; Koo MY; Hur SM; Choi MY; Cho DH; Choe JH; Kim JH; Kim JS
    Thyroid; 2011 Sep; 21(9):1027-31. PubMed ID: 21834676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma.
    Simon D; Goretzki PE; Witte J; Röher HD
    World J Surg; 1996 Sep; 20(7):860-6; discussion 866. PubMed ID: 8678963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraoperative diagnosis of central compartment lymph node metastasis predicts recurrence of patients with papillary thyroid carcinoma and clinically node-negative lateral neck and may guide extent of initial surgery.
    Lee CW; Gong G; Roh JL
    World J Surg; 2015 Jan; 39(1):194-202. PubMed ID: 25234198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.